These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 36882523)
1. E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression. Zhou P; Peng X; Tang S; Zhang K; Tan Z; Li D; Shen L; Peng J; Yang L Oncogene; 2023 Apr; 42(16):1308-1320. PubMed ID: 36882523 [TBL] [Abstract][Full Text] [Related]
2. TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance. Li Y; Wang T; Wan Q; Wang Q; Chen Z; Gao Y; Ye Y; Lin J; Zhao B; Wang H; Yang J; Zhao K; Lu N Cancer Res; 2022 Oct; 82(19):3573-3587. PubMed ID: 35895752 [TBL] [Abstract][Full Text] [Related]
3. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition. Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243 [TBL] [Abstract][Full Text] [Related]
4. CHIP promotes CAD ubiquitination and degradation to suppress the proliferation and colony formation of glioblastoma cells. Li G; Xiao K; Li Y; Gao J; He S; Li T Cell Oncol (Dordr); 2024 Jun; 47(3):851-865. PubMed ID: 37982961 [TBL] [Abstract][Full Text] [Related]
5. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance. Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507 [TBL] [Abstract][Full Text] [Related]
6. Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis. Yan Y; Zhou S; Chen X; Yi Q; Feng S; Zhao Z; Liu Y; Liang Q; Xu Z; Li Z; Sun L Signal Transduct Target Ther; 2024 Mar; 9(1):58. PubMed ID: 38438346 [TBL] [Abstract][Full Text] [Related]
7. TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1. Wei J; Wang L; Zhang Y; Sun T; Zhang C; Hu Z; Zhou L; Liu X; Wan J; Ma L Oncogene; 2023 Jun; 42(26):2103-2112. PubMed ID: 37188737 [TBL] [Abstract][Full Text] [Related]
8. HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma. Li H; Li J; Chen L; Qi S; Yu S; Weng Z; Hu Z; Zhou Q; Xin Z; Shi L; Ma L; Huang A; Lu Y Clin Cancer Res; 2019 Jun; 25(12):3602-3616. PubMed ID: 30862693 [TBL] [Abstract][Full Text] [Related]
9. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma. Chen Z; Wei X; Shen L; Zhu H; Zheng X Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207 [TBL] [Abstract][Full Text] [Related]
10. Propofol enhances the sensitivity of glioblastoma cells to temozolomide by inhibiting macrophage activation in tumor microenvironment to down-regulate HIF-1α expression. Zhao W; Yun K Exp Cell Res; 2022 Sep; 418(2):113277. PubMed ID: 35810776 [TBL] [Abstract][Full Text] [Related]
11. CHIP-mediated ubiquitin degradation of BCAT1 regulates glioma cell proliferation and temozolomide sensitivity. Lu Z; Wang XY; He KY; Han XH; Wang X; Zhang Z; Qu XH; Chen ZP; Han XJ; Wang T Cell Death Dis; 2024 Jul; 15(7):538. PubMed ID: 39075053 [TBL] [Abstract][Full Text] [Related]
12. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance. Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522 [TBL] [Abstract][Full Text] [Related]
13. MAEA is an E3 ubiquitin ligase promoting autophagy and maintenance of haematopoietic stem cells. Wei Q; Pinho S; Dong S; Pierce H; Li H; Nakahara F; Xu J; Xu C; Boulais PE; Zhang D; Maryanovich M; Cuervo AM; Frenette PS Nat Commun; 2021 May; 12(1):2522. PubMed ID: 33947846 [TBL] [Abstract][Full Text] [Related]
14. Cross-talk between BCKDK-mediated phosphorylation and STUB1-dependent ubiquitination degradation of BCAT1 promotes GBM progression. Wang W; Li Y; Tang L; Shi Y; Li W; Zou L; Zhang L; Cheng Y; Yuan Z; Zhu F; Duan Q Cancer Lett; 2024 Jun; 591():216849. PubMed ID: 38621458 [TBL] [Abstract][Full Text] [Related]
15. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme. Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285 [TBL] [Abstract][Full Text] [Related]
16. PSMG3-AS1 enhances glioma resistance to temozolomide via stabilizing c-Myc in the nucleus. Zhou L; Huang X; Zhang Y; Wang J; Li H; Huang H Brain Behav; 2022 May; 12(5):e2531. PubMed ID: 35380741 [TBL] [Abstract][Full Text] [Related]
17. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting. Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456 [TBL] [Abstract][Full Text] [Related]
18. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma. Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways. Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257 [TBL] [Abstract][Full Text] [Related]
20. Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide. Ding Y; Zhang C; He L; Song X; Zheng C; Pan Y; Yu S Bioengineered; 2021 Dec; 12(2):10791-10798. PubMed ID: 34753395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]